Amarin Corp Plc (AMRN)

[Jt0082]

From the article: "For example, Amgen announced positive topline findings for the cholesterol drug Repatha in 2017; there was disappointment when the actual study was presented several months later"

Anyone know the details about Repatha and why people were disappointed several months later??

I thought one of the study committee members said something like 'every topline result in CV outcomes studies has matched the full publication results'?